Riverain Technologies logo, featuring an abstract symbol on the left and the text "Riverain Technologies" on the right.

See Clearly.
Decide Confidently.

Empowering healthcare providers by streamlining diagnostic processes, improving detection accuracy, and improving outcomes for patients with cardiothoracic conditions. 

ClearReadCT logo featuring a stylized blue symbol and the text 'ClearReadCT'

Incidental Detection of Pulmonary Nodules and Coronary Artery Calcification (CAC)

Lung cancer and coronary artery disease are leading causes of death worldwide, and early detection is key to improving outcomes. Coronary artery calcification (CAC) affects 20 million Americans annually, yet over half of incidental findings go unreported.12,13 Lung cancer is the leading cause of cancer death, and screening for nodules is burdensome; moreover, blood vessels can obscure findings, delaying diagnosis. Comparing findings over time, segmenting them, and quantifying them is time-consuming. In addition, the exploding volume of imaging data, combined with radiologist shortages and burnout, has reached a breaking point. 

ClearRead CT with Clear Visual Intelligence provides a clear view of the chest for efficient and accurate detection of cardiothoracic diseases. The full suite of tools detects, segments, and measures nodules, compares findings with previous exams, quantifies CAC, and automatically integrates with the radiology report. ClearRead CT is a natural addition for opportunistic CAC and nodule detection or as part of a lung cancer screening program. Detect 29% more nodules and read 36% faster.2,14

A printout of a medical image from a chest CT scan with annotations for the detection and screening of pulmonary nodules, including steps for identification, comparison, detection, and removal of blood vessels, with text explaining each step.